ENSYSCE BIOSCIENCES INC (ENSC) Stock Balance Sheet
USA - NASDAQ:ENSC - US2936025046 - Common Stock
2.14 USD
-0.09 (-4.04%)
2.1 USD
-0.04 (-1.87%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | N/A | |||
| Cash Equivalents | 2.21M | N/A | 1.12M | 3.10M | 12.30M | |||
| Receivables | 1.21M | 120.00K | 100.00K | 300.00K | 400.00K | |||
| Other Current Assets | 1.86M | 1.72M | 1.07M | 1.80M | 2.90M | |||
| Total Current Assets | 5.28M | 5.34M | 2.29M | 5.30M | 15.70M | |||
| Non-Current Assets | ||||||||
| PPE Net | N/A | N/A | 0.00 | 0.00 | 0.00 | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 292.90K | 250.00K | 420.00K | 600.00K | 800.00K | |||
| Total Non-Current Assets | 292.90K | 260.00K | 420.00K | 600.00K | 700.00K | |||
| TOTAL ASSETS | 5.57M | 5.60M | 2.71M | 5.90M | 16.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 424.50K | 300.00K | 850.00K | 4.30M | 12.70M | |||
| Accrued Expenses | 1.05M | 550.00K | 540.00K | 2.30M | 3.40M | |||
| Accounts Payable | 1.04M | 1.36M | 1.94M | 2.90M | 300.00K | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 2.51M | 2.21M | 3.33M | 9.50M | 16.50M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 100.00K | 4.40M | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 1.00K | 10.00K | 30.00K | 300.00K | 3.70M | |||
| Total Non-Current Liabilities | -327.60K | -320.00K | -300.00K | 100.00K | 7.80M | |||
| TOTAL LIABILITIES | 2.19M | 1.89M | 3.03M | 9.60M | 24.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -133.22M | -130.00M | -122.00M | -110.90M | -85.80M | |||
| Additional Paid In Capital | 136.61M | 133.00M | 121.00M | 107.20M | 78.00M | |||
| Minority Interest | -328.70K | -330.00K | -330.00K | -300.00K | -300.00K | |||
| Common Shares | 200.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Shares Outstanding | 2.39M | 1.36M | 209.80K | 35.60K | 6.90K | |||
| Tangible Book Value per Share | 1.42 | N/A | -0.10 | -7.40 | -79.00 | |||
| Total Shareholders' Equity | 3.39M | 3.71M | -320.00K | -3.70M | -7.90M | |||
| TOTAL LIABILITIES AND EQUITY | 5.57M | 5.60M | 2.71M | 5.90M | 16.40M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | -0.03 | -0.56 | |||
| Current Ratio | 2.10 | 2.42 | 0.69 | 0.56 | 0.95 | |||
| Return On Assets (ROA) | -118.07% | -142.63% | -392.10% | -425.25% | -182.26% | |||
| Return On Equity (ROE) | -194.20% | -215.29% | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21